1 Russell 2000 Stock with Solid Fundamentals and 2 to Steer Clear Of [Yahoo! Finance]
ANI Pharmaceuticals, Inc. (ANIP)
Last ani pharmaceuticals, inc. earnings: 2/27 08:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
anipharmaceuticals.com/investors_corporate_profile.php
Company Research
Source: Yahoo! Finance
However, smaller size also means these businesses often lack the resilience and financial flexibility of large-cap firms, making careful selection crucial. The high-risk, high-reward nature of the Russell 2000 makes stock selection critical, and we're here to guide you toward the right ones. Keeping that in mind, here is one Russell 2000 stock that could deliver strong gains and two that may struggle to keep up. Market Cap: $1.73 billion With over five decades of experience in surgical innovation since its founding in 1970, CONMED (NYSE:CNMD) develops and manufactures medical devices and equipment for surgical procedures, specializing in orthopedic and general surgery products. Why Do We Think Twice About CNMD? Sales trends were unexciting over the last five years as its 6.7% annual growth was below the typical healthcare company Subscale operations are evident in its revenue base of $1.32 billion, meaning it has fewer distribution channels than its larger rivals Low ret
Show less
Read more
Impact Snapshot
Event Time:
ANIP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANIP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANIP alerts
High impacting ANI Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ANIP
News
- Assessing ANI Pharmaceuticals (ANIP) Valuation After a Strong Yearly Share Price Rally [Yahoo! Finance]Yahoo! Finance
- Is ANI Pharmaceuticals Stock Price Justified After 47% 2025 Rally? [Yahoo! Finance]Yahoo! Finance
- How Investors May Respond To ANI Pharmaceuticals (ANIP) Creating a Retina-Focused FutureVision Advisory Council [Yahoo! Finance]Yahoo! Finance
- Implied Volatility Surging for ANI Pharmaceuticals Stock Options [Yahoo! Finance]Yahoo! Finance
- ANI Pharmaceuticals (NASDAQ:ANIP) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $100.00 price target on the stock.MarketBeat
ANIP
Earnings
- 11/7/25 - Beat
ANIP
Sec Filings
- 12/19/25 - Form 4
- 12/12/25 - Form 4
- 12/9/25 - Form 4
- ANIP's page on the SEC website